A Randomized Multicenter Study for Isolated Skin Vasculitis (ARAMIS)

A Randomized Multicenter Study for Isolated Skin Vasculitis (ARAMIS)
Recruiting
99 years or below
All
1 Location

Brief description of study

The purpose of this study is to evaluate different treatment options for patients with skin vasculitis (also named cutaneous vasculitis). Patients with isolated cutaneous small vessel vasculitis, medium-sized vessel vasculitis (polyarteritis nodosa), or IgA vasculitis (Henoch-Schönlein purpura) can join this study. The frequently used treatments for skin vasculitis are colchicine, dapsone and azathioprine. Eligible patients will initially be randomized to receive one of the 3 medications under investigation for 6 months (stage 1). Subjects may remain on the drug for stage 2, or they may be randomized to one of the remaining drugs. The study will compare how effective these drugs are at treating isolated cutaneous vasculitis.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: ['Primary Cutaneous Vasculitis', 'Cutaneous Polyarteritis Nodosa', 'IgA Vasculitis', 'Henoch-Schönlein Purpura']
  • Age: 99 years or below
  • Gender: All
Updated on 19 Feb 2024. Study ID: 825128

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.